NCT00403221View on ClinicalTrials.gov

Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Prostatic Neoplasms
Interventions
GENETIC

RTVP-1 Gene

"Cohort Level #1 1.0 x 1010vp Cohort Level #2 5.0x1010vp Cohort Level #3 1.0 x 1011vp Cohort Level #4 5.0x1011vp Cohort Level #5 1.0 x 1012vp Cohort Level #6 5.0x1012vp~One dose only followed by a radical prostatectomy 4 weeks later."

Trial Locations (1)

77030

Baylor College of Medicine - Scott Department of Urology, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER

NCT00403221 - Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer | Biotech Hunter | Biotech Hunter